Status:
UNKNOWN
Neutrophil Gelatinase Associated Liocalin in Predicting AKI in Coronary Artery Disease
Lead Sponsor:
Assiut University
Conditions:
Acute Kidney Injury
Eligibility:
All Genders
20-70 years
Brief Summary
The aim of this work is to assess the clinical significance of serum levels of neutrophil gelatinase-associated lipocalin (NGAL) to predict AKI in patients exposed to PCI.
Detailed Description
ST-elevated myocardial infarction(STEMI) patients are at a particularly high risk of acute kidney injury (AKI) because of the complexity of hemodynamic disorders and adverse effects associated with th...
Eligibility Criteria
Inclusion
- patients exposed to percutaneous coronary intervention
Exclusion
- Diabetes mellitus 2.Liver disease 3.Chronic Kidney Disease 4.Renal Replacement Therapy 5.Previous kidney transplant 6.Chronic infection
Key Trial Info
Start Date :
September 15 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 15 2019
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03266367
Start Date
September 15 2017
End Date
September 15 2019
Last Update
September 5 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.